Posted 26 January, 2024
ArriVent Biopharma, Inc. IPO completed
IPO completed detected for ticker Nasdaq:AVBP in a 424B4 filed on 26 January, 2024.
This is an initial public offering of shares of common stock of ArriVent BioPharma, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of ArriVent Biopharma, Inc.
Health Care/Life Sciences • Biotechnology
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.Market Cap
$664M
View Company Details
$664M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.